Obstructive Sleep Apnea: Beyond Snoring — the Heart and Brain Risks Untreated OSA Causes

Obstructive Sleep Apnea is far more than a nighttime nuisance that makes people snore loudly. It is a serious medical condition in which the upper airway repeatedly collapses during sleep, causing breathing to stop and restart dozens or even hundreds of times each night. Every pause in breathing triggers a cascade of physiological stress responses that, over time, cause profound damage to the heart, brain, and blood vessels.

Most people with Obstructive Sleep Apnea, commonly abbreviated as OSA, remain completely undiagnosed. Their partners may notice the snoring or the gasping, but the person themselves often feels merely tired without understanding why. This diagnostic gap is dangerous, because untreated OSA silently increases the risk of heart attack, stroke, heart failure, irregular heart rhythms, and cognitive decline. Understanding OSA in its full clinical seriousness is the first step toward protecting long-term health.

What Is Obstructive Sleep Apnea?

Obstructive Sleep Apnea is the most common form of sleep-disordered breathing. During sleep, the muscles of the throat and tongue relax. In people with OSA, this relaxation allows the soft tissues at the back of the throat to collapse inward, partially or completely blocking the upper airway.

Each blockage, called an apnoea, causes breathing to stop for ten seconds or longer. The brain detects the resulting drop in oxygen and triggers a brief arousal, meaning a partial awakening, to restore muscle tone and reopen the airway. Breathing resumes, often with a loud gasp or snort, before the person drifts back to sleep.

The Cycle of Disruption

This cycle of obstruction, oxygen drop, arousal, and recovery can repeat five to over a hundred times every hour throughout the night. Each arousal fragments sleep architecture, preventing the deep, restorative sleep stages the brain and body require. Simultaneously, each oxygen drop, called hypoxia, stresses the cardiovascular system with a surge of adrenaline and inflammatory signals.

Over weeks, months, and years, this repeated physiological assault accumulates into serious systemic damage, particularly affecting the heart, blood vessels, and brain.

How OSA Differs From Simple Snoring

Simple snoring occurs when airflow causes throat tissues to vibrate without fully obstructing the airway. OSA involves actual airway obstruction with measurable oxygen desaturation and sleep fragmentation. Not all snorers have OSA, but most people with OSA do snore. The critical distinction lies in whether breathing actually stops and oxygen levels fall.

How Common Is Obstructive Sleep Apnea?

OSA is remarkably prevalent worldwide, yet most cases remain undiagnosed. Global estimates suggest that approximately one billion adults have at least mild OSA, with around 425 million experiencing moderate to severe disease, according to research published in the Lancet Respiratory Medicine.

OSA affects people of all ages, genders, and ethnicities. However, middle-aged and older adults carry the highest prevalence. Men develop OSA roughly twice as often as pre-menopausal women, though the gender gap narrows significantly after menopause.

The Underdiagnosis Problem

Despite its prevalence, most people with clinically significant OSA have never received a diagnosis. Estimates suggest that up to 80 percent of moderate to severe OSA cases remain unidentified in the general population. This underdiagnosis reflects a combination of poor public awareness, attribution of symptoms to lifestyle factors, and limited access to sleep testing in many healthcare systems.

The consequences of this diagnostic gap extend far beyond poor sleep. Every undiagnosed year represents continued exposure to the cardiovascular, metabolic, and neurological harms that untreated OSA reliably produces.

Causes and Risk Factors for OSA

Several anatomical, physiological, and lifestyle factors increase the risk of developing Obstructive Sleep Apnea.

Anatomical Risk Factors

The physical structure of the upper airway significantly influences OSA risk. A narrow airway, large tonsils or adenoids, a large tongue, a small or receding jaw, and excess soft tissue in the throat all predispose individuals to airway collapse during sleep. These anatomical features may be genetic, developmental, or acquired through weight gain.

Nasal obstruction from a deviated septum, nasal polyps, or chronic congestion also increases OSA risk by forcing mouth breathing and altering airway dynamics during sleep.

Obesity and Weight

Obesity is the single most important modifiable risk factor for OSA. Excess weight, particularly fat deposited around the neck and throat, narrows the upper airway and increases its tendency to collapse. A neck circumference exceeding 40 centimetres in women or 43 centimetres in men correlates strongly with OSA risk.

Even modest weight gain can trigger OSA in susceptible individuals. Conversely, meaningful weight loss often produces significant OSA improvement, sometimes achieving complete resolution in people with obesity-related disease.

Age and Hormonal Factors

OSA prevalence increases steadily with age, reflecting progressive loss of upper airway muscle tone and changes in sleep architecture. After menopause, women’s OSA rates approach those of men of similar age, suggesting that oestrogen and progesterone exert protective effects on upper airway muscle tone during reproductive years.

Hypothyroidism, meaning an underactive thyroid gland, and acromegaly, a hormonal disorder causing abnormal growth, both increase OSA risk through airway tissue changes.

Lifestyle and Behavioural Factors

Alcohol consumption significantly worsens OSA by relaxing upper airway muscles further and suppressing the brain’s arousal response. Sedative medications including benzodiazepines and opioids carry similar effects. Smoking causes upper airway inflammation and fluid retention, increasing collapse tendency.

Sleeping in the supine position, meaning lying flat on the back, worsens OSA in many people by allowing gravity to displace the tongue and soft palate backward into the airway.

Recognising the Symptoms of Obstructive Sleep Apnea

OSA produces a characteristic cluster of symptoms, though many people attribute them to other causes or simply accept them as normal features of ageing or busy lives.

Nighttime Symptoms

Loud, habitual snoring is the most recognised nighttime symptom of OSA. Witnessed apnoeas, where a bed partner observes breathing pauses followed by gasping or choking, represent the most specific nighttime indicator of OSA. Restless sleep, frequent nighttime awakenings, nocturia meaning waking to urinate, and night sweats also commonly occur.

Many people with OSA report waking with a dry mouth, sore throat, or morning headache, each reflecting the effects of mouth breathing and overnight oxygen fluctuations.

Daytime Symptoms

Excessive daytime sleepiness is the most debilitating daytime consequence of OSA. People with significant OSA often fall asleep involuntarily during sedentary activities, reading, watching television, or even driving. This sleepiness reflects the cumulative effect of hundreds of nightly arousals destroying restorative sleep.

Cognitive symptoms including poor concentration, memory difficulties, and impaired decision-making are highly prevalent in OSA. Many people notice reduced work performance, increased irritability, and mood disturbances, sometimes misattributed to depression or stress.

When OSA Presents Without Obvious Sleepiness

Not everyone with OSA reports excessive daytime sleepiness, particularly in milder cases or among individuals who have adapted to chronic sleep deprivation. Some people present primarily with cardiovascular conditions such as treatment-resistant hypertension or atrial fibrillation, with OSA identified only on subsequent investigation.

Recognising these atypical presentations is vital for ensuring that people with OSA receive diagnosis and treatment regardless of their predominant symptom pattern.

The Heart Risks of Untreated Obstructive Sleep Apnea

The cardiovascular consequences of untreated OSA represent its most serious and life-shortening dimension. The repeated cycles of hypoxia, arousal, and adrenaline surges inflict cumulative damage on the heart and blood vessels over time.

Hypertension

Hypertension, meaning high blood pressure, is the most prevalent cardiovascular consequence of OSA. Each apnoeic episode triggers a sympathetic nervous system surge that acutely raises blood pressure. With dozens of episodes nightly, this effect sustains elevated blood pressure around the clock, including during the day.

OSA is the most common identifiable cause of secondary hypertension. Critically, many people with OSA have hypertension that responds poorly to standard blood pressure medications. Treating the underlying OSA often improves blood pressure control significantly, sometimes reducing medication requirements.

Coronary Artery Disease and Heart Attack

Untreated OSA accelerates atherosclerosis, the build-up of fatty plaques inside coronary arteries. Repeated hypoxia and inflammation damage arterial walls, promote plaque formation, and increase the tendency for plaques to rupture, triggering heart attacks. People with severe untreated OSA face approximately twice the risk of non-fatal heart attack compared to people without OSA.

The highest cardiovascular risk period in OSA coincides with early morning hours, when REM sleep predominates and apnoeic episodes are most prolonged and severe. Heart attacks and sudden cardiac death show a corresponding peak in early morning in people with OSA.

Heart Failure

OSA contributes to heart failure through multiple mechanisms. Repeated hypoxia weakens heart muscle, elevated blood pressure increases the heart’s workload, and activation of the renin-angiotensin system promotes cardiac remodelling. Both systolic heart failure, where the heart pumps weakly, and diastolic heart failure, where the heart stiffens and fills poorly, associate with OSA.

Conversely, heart failure itself worsens sleep-disordered breathing, creating a bidirectional cycle that accelerates both conditions simultaneously.

Atrial Fibrillation

Atrial fibrillation, an irregular and often rapid heart rhythm originating in the upper chambers of the heart, associates strongly with OSA. Repeated overnight hypoxia, autonomic nervous system disruption, and increased atrial wall stress all promote atrial fibrillation development. People with OSA have roughly a twofold increased risk of developing atrial fibrillation.

Furthermore, OSA significantly reduces the effectiveness of treatments for atrial fibrillation, including cardioversion and catheter ablation procedures. Treating OSA improves atrial fibrillation outcomes, making sleep apnea assessment a standard part of atrial fibrillation management in leading cardiac centres.

The Brain Risks of Untreated Obstructive Sleep Apnea

Beyond the heart, untreated OSA exerts a profound and progressive toll on the brain. The neurological consequences range from reversible cognitive impairment to increased stroke risk and potential contributions to dementia.

Stroke

OSA is an independent risk factor for ischaemic stroke, meaning stroke caused by a blocked blood vessel in the brain. The mechanisms linking OSA to stroke are multiple and interconnected. Hypertension, atrial fibrillation, accelerated atherosclerosis, hypercoagulability meaning increased blood clotting tendency, and direct hypoxic brain injury all contribute.

Studies suggest that moderate to severe untreated OSA approximately doubles the risk of stroke. Nighttime strokes occur more frequently in people with OSA than in those without, reflecting the particular vulnerability of the sleeping brain to hypoxic and haemodynamic stressors.

Cognitive Impairment

Chronic sleep fragmentation and intermittent hypoxia both impair brain function in ways that extend beyond simple tiredness. People with untreated OSA show measurable deficits in attention, processing speed, working memory, and executive function, meaning the ability to plan, organise, and make decisions.

Neuroimaging studies demonstrate grey matter loss in brain regions responsible for memory, attention, and emotional regulation in people with chronic OSA. These structural brain changes partially reverse with effective treatment, particularly in younger individuals, but persistent damage can occur with prolonged untreated disease.

OSA and Dementia Risk

Emerging research suggests that untreated OSA may increase the risk of Alzheimer’s disease and other dementias. The proposed mechanisms include impaired clearance of amyloid-beta protein, a toxic waste product that accumulates in Alzheimer’s disease, during disrupted sleep. The glymphatic system, a brain waste-clearance mechanism that operates primarily during deep sleep, functions poorly when OSA fragments slow-wave sleep.

Several large longitudinal studies report higher dementia rates in people with untreated OSA compared to matched controls. Whether aggressive OSA treatment reduces dementia risk remains an active and important area of research.

Mental Health Consequences

Depression and anxiety are significantly more prevalent in people with untreated OSA compared to the general population. The relationship is bidirectional. OSA causes mood disturbances through sleep deprivation and neurochemical disruption, while depression independently worsens sleep quality. Many people with apparent treatment-resistant depression experience substantial improvement after OSA diagnosis and treatment.

Diagnosing Obstructive Sleep Apnea

Accurate OSA diagnosis requires objective sleep testing rather than symptom assessment alone, as symptoms correlate poorly with disease severity in many individuals.

Clinical Assessment and Screening Tools

Clinicians use validated questionnaires to screen for OSA risk. The STOP-BANG questionnaire assesses eight risk factors including snoring, tiredness, observed apnoeas, blood pressure, BMI, age, neck circumference, and gender. Higher scores indicate greater OSA probability and guide referral for objective sleep testing.

The Epworth Sleepiness Scale quantifies daytime sleepiness by asking people to rate their likelihood of dozing in eight common situations. While useful, sleepiness scores alone cannot confirm or exclude OSA.

Polysomnography

In-laboratory polysomnography remains the gold standard for OSA diagnosis. This comprehensive overnight sleep study simultaneously records brain activity, eye movements, muscle activity, heart rhythm, airflow, respiratory effort, oxygen saturation, and body position. Specialist technicians score the results to calculate the Apnoea-Hypopnoea Index (AHI), the number of apnoeic and hypopnoeic events per hour of sleep.

AHI classification defines OSA severity: mild disease involves five to fourteen events per hour, moderate disease involves fifteen to twenty-nine events, and severe disease involves thirty or more events per hour.

Home Sleep Testing

Home sleep apnea testing using portable monitoring devices offers a simpler, more accessible, and less expensive alternative to laboratory polysomnography for uncomplicated suspected OSA. These devices typically measure airflow, respiratory effort, oxygen saturation, and heart rate during sleep at home.

Home testing suits people with a high pre-test probability of moderate to severe OSA and no significant complicating conditions. It may underestimate AHI compared to full polysomnography and is less suitable for people with suspected central sleep apnea, significant comorbidities, or diagnostic uncertainty.

Treatment of Obstructive Sleep Apnea

Effective OSA treatment eliminates apnoeic events, restores normal sleep architecture, prevents nocturnal hypoxia, and reduces the associated cardiovascular and neurological risks.

Continuous Positive Airway Pressure Therapy

Continuous Positive Airway Pressure, universally known as CPAP, is the most effective and widely used treatment for moderate to severe OSA. CPAP delivers a continuous stream of pressurised air through a mask worn over the nose or nose and mouth during sleep. This pressurised air acts as a pneumatic splint, keeping the upper airway open and preventing collapse throughout the night.

CPAP eliminates apnoeic events effectively in the vast majority of users. Regular nightly use of at least four hours is necessary to achieve meaningful cardiovascular and neurocognitive benefits.

CPAP Adherence Challenges

Despite CPAP’s effectiveness, adherence remains a significant clinical challenge. Many people find the mask uncomfortable, experience claustrophobia, or struggle with pressure sensation or nasal dryness. Modern CPAP machines with heated humidification, pressure ramp-up features, and auto-titrating algorithms have significantly improved comfort and acceptance.

Structured patient education, early follow-up to address mask fit issues, and ongoing support from sleep technicians all improve long-term CPAP adherence substantially.

Mandibular Advancement Devices

Mandibular advancement devices, also called dental sleep appliances, are custom-fitted oral devices worn during sleep. They work by advancing the lower jaw and tongue forward, enlarging the upper airway and reducing its tendency to collapse. These devices suit mild to moderate OSA and people who cannot tolerate CPAP therapy.

Mandibular devices are less effective than CPAP for severe OSA but show good evidence for improving AHI, sleepiness, and cardiovascular markers in appropriate candidates.

Weight Loss and Lifestyle Modification

Weight loss produces significant OSA improvement in people with obesity-related disease. Even a ten percent reduction in body weight can reduce AHI by approximately 26 percent. Bariatric surgery, producing larger and more sustained weight loss, can resolve OSA completely in a substantial proportion of severely obese patients.

Positional therapy, using devices or techniques to prevent supine sleeping, benefits people whose OSA occurs predominantly when lying on their back. Alcohol avoidance, smoking cessation, and optimising nasal breathing also contribute meaningfully to OSA management.

Surgical Options

Surgery aims to enlarge the upper airway by removing or repositioning obstructing tissues. Uvulopalatopharyngoplasty, a procedure removing excess throat tissue, benefits selected patients, particularly those with specific anatomical obstruction patterns. Tonsillectomy and adenoidectomy produce high cure rates in children with OSA caused by enlarged tonsils.

Hypoglossal nerve stimulation, a newer surgical approach implanting a device that electrically stimulates the tongue nerve during sleep to prevent airway collapse, shows excellent results in carefully selected adults who cannot use CPAP.

OSA in Special Populations

OSA presents distinct considerations in certain groups that deserve specific attention.

OSA in Children

Childhood OSA differs substantially from adult disease. In children, enlarged tonsils and adenoids cause most cases rather than obesity or loss of muscle tone. Symptoms include snoring, restless sleep, mouth breathing, bedwetting, and behavioural problems including hyperactivity and attention difficulties that may mimic ADHD.

Tonsillectomy and adenoidectomy resolve OSA in the majority of affected children, producing dramatic improvements in behaviour, school performance, and quality of life.

OSA in Women

OSA in women is frequently underdiagnosed because its presentation often differs from the classic male pattern. Women more commonly report fatigue, insomnia, morning headache, and mood disturbances rather than loud snoring or witnessed apnoeas. Clinicians may attribute these symptoms to depression, anaemia, or thyroid disease, delaying OSA diagnosis by years.

Pregnancy significantly increases OSA risk, and gestational OSA associates with pre-eclampsia, gestational diabetes, and adverse fetal outcomes. Screening for OSA during pregnancy is increasingly recommended in women with relevant risk factors.

Frequently Asked Questions

What is Obstructive Sleep Apnea?

Obstructive Sleep Apnea is a common sleep disorder in which the upper airway repeatedly collapses during sleep, causing breathing to stop temporarily. Each pause, called an apnoea, triggers oxygen drops and partial awakenings that fragment sleep and stress the cardiovascular system. Untreated OSA significantly increases the risk of heart disease, stroke, cognitive impairment, and other serious health conditions.

How do I know if I have sleep apnea?

Common signs of OSA include loud habitual snoring, witnessed breathing pauses during sleep, waking with gasping or choking, morning headaches, excessive daytime sleepiness, and difficulty concentrating. However, some people with significant OSA experience minimal obvious symptoms. If you or your partner notices any of these signs, consult a healthcare provider for a formal sleep assessment.

Is snoring always a sign of sleep apnea?

Not necessarily. Simple snoring occurs when throat tissues vibrate during sleep without fully blocking the airway or causing oxygen drops. OSA involves actual airway obstruction with measurable oxygen desaturation and sleep disruption. While most people with OSA do snore, not all snorers have OSA. A sleep study determines whether breathing actually stops and oxygen levels fall during sleep.

Can sleep apnea cause a heart attack?

Yes. Untreated OSA significantly increases the risk of heart attack, heart failure, hypertension, and atrial fibrillation through repeated cycles of overnight hypoxia, adrenaline surges, and systemic inflammation. People with severe untreated OSA face roughly twice the heart attack risk compared to those without OSA. Effective CPAP treatment reduces cardiovascular risk, though the degree of risk reduction depends on treatment adherence and duration.

Does CPAP therapy really work?

Yes. CPAP is the most effective treatment for moderate to severe OSA and eliminates apnoeic events in the vast majority of users. Regular nightly CPAP use improves daytime sleepiness, cognitive function, mood, blood pressure control, and reduces cardiovascular event risk. The key to success is consistent nightly use. Many people experience dramatic quality-of-life improvements within days of starting effective CPAP therapy.

Can children have sleep apnea?

Yes. Childhood OSA is relatively common and most frequently caused by enlarged tonsils and adenoids rather than obesity. Children with OSA may snore, breathe through their mouths, sleep restlessly, and show behavioural problems or learning difficulties during the day. Tonsillectomy and adenoidectomy resolve OSA in most affected children, often producing remarkable improvements in behaviour and academic performance.

Disclaimer:

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis, treatment, or medical guidance related to any health condition.

References:

1. World COPD Day was established to raise awareness about Chronic Obstructive Pulmonary Disease (COPD) and promote actions to improve respiratory health globally.
2. Ever flipped a coin and wondered if it had a mind of its own?
3. Indian Institute of Technology, Ropar has developed a device ‘Jivan Vayu’ which can be used as a substitute for a CPAP machine. 

Observer Voice is the one stop site for National, International news, Sports, Editor’s Choice, Art/culture contents, Quotes and much more. We also cover historical contents. Historical contents includes World History, Indian History, and what happened today. The website also covers Entertainment across the India and World.

Follow Us on Twitter, Instagram, Facebook, & LinkedIn